MS4A1 Expression | Cancer Search

Details 76 Trials 8 Therapies

mutation class

Gene Expression

synonyms

CD20

CD20+

CD20+ve

CD20(+)

CD20-pos

CD20-positive

CD20 positive

Expressing CD20

CD20-expressing

CD20 expressing

CD20 Expression

Positive for CD20

B-lymphocyte antigen CD20 Positive

Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients

281 sites for NCT04824092

ALK Fusion, +4 more biomarkers

ALK-Positive Large B-Cell Lymphoma, +7 more conditions

cyclophosphamide, +6 more drugs

chemotherapy, +3 more types

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

198 sites for NCT03267433

CCND1 Expression, +4 more biomarkers

Mantle Cell Lymphoma

autologous hematopoietic stem cell transplantation, +2 more drugs

cellular therapy, +2 more types

Testing The Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

557 sites for NCT03737981

CD19 Expression, +2 more biomarkers

Chronic Lymphocytic Leukemia

ibrutinib, +2 more drugs

chemotherapy, +2 more types

A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Participants With Previously Untreated CLL or SLL

144 sites for NCT03336333

del(17)(p10), +1 more biomarker

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

bendamustine, +3 more drugs

chemotherapy, +2 more types

Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)